معرفی
Helene Haguet is a Researcher at the Namur Research Institute for Life Sciences, specializing in clinical pharmacology and hematology. She earned her Doctorate in Biomedical and Pharmaceutical Sciences in 2022 with a thesis on cardiovascular risks associated with BCR-ABL tyrosine kinase inhibitors.
Her research focuses on:
- Mechanisms of drug-induced thrombosis
- COVID-19 coagulopathies and biomarkers
- Kinase inhibitor safety profiles
- Nanoparticle applications in coagulation
- Pediatric drug development modeling
Her publications emphasize translational studies in hematology, COVID-19 complications, and nanotechnology-based antimicrobial solutions, frequently employing clinical observational methodologies.
Awards:
- Prix Léo Pharma Cancer & Thrombosis (2017)
She actively contributes to multi-year projects including:
- ERAMET (Modeling for orphan/paediatric medicines, 2024–2027)
- COVILAB (COVID-19 laboratory investigations, 2020–present)
- Drug-Induced Thrombosis project (2015–present)
۰مقاله منتشرشده
